Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb - Research Grade |
|---|---|
| Source | CAS 1353485-38-7 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Enoblituzumab,MG-A271,CD276, B7-H3,anti-CD276, B7-H3 |
| Reference | PX-TA1410 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb - Research Grade
General information on Anti-CD276/B7-H3[Homo sapiens] (Enoblituzumab) Monoclonal Antibody
Enoblituzumab is investigated for the treatment of B7-H3-expressing Solid Tumors.
SDS-PAGE for Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb
Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Immobilized CD276 Recombinant Protein (cat. No.PX-P4125) at 0.5µg/mL (100µL/well) can bind to Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb (cat. No.PX-TA1410) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Antigen
CD276 Recombinant Protein
PX-P4125 500$
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 215$
ELISA
Enoblituzumab ELISA Kit
KPTX265 1404$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.